Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Vodafone Group Plc And GlaxoSmithKline plc Link On African Vaccines Programme-Reuters


Monday, 10 Dec 2012 02:51am EST 

Reuters reported that Vodafone Group Plc and drugmaker GlaxoSmithKline plc are joining forces on a novel project to increase childhood vaccination rates in Mozambique using text messaging. At the same time Vodafone has formed a strategic partnership with the non-profit GAVI Alliance to study how health ministries across sub-Saharan Africa can use mobile technology to improve their immunisation programmes. The move is the latest example of mobile phones being used to improve healthcare in Africa. Now widespread across the continent, mobile phones are already deployed in other schemes, including ones to check that people are taking HIV/AIDS drugs properly. The one-year pilot project in Mozambique, supported by the Save the Children charity, will register mothers on a ministry of health database, alert them to the availability of vaccinations and allow them to schedule appointments by text. The aim is to increase the proportion of children covered by vaccination by an additional 5% to 10%.